CW September 2000Issue Number 9 September 2000 ISSN 10593802 New Antifungal Drug for Serious InfectionCancidas™, an investigational antifungal drug, demonstrated favorable response in many patients who were unresponsive or intolerant to prior antifungal therapy. In certain cases this drug may be more beneficial if used in combination with other antifungal agent such as amphotericin B.
Go to Previous Page Go to Next Page Source & Additional Reading T. Walsh et al., 40th meeting of the Intersciences Conference on Antimicrobial Agents and Chemotherapy (ICAAC) held in Toronto on September 18, 2000. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW September 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |